About: Calcilytic

An Entity of Type: drug, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Calcilytics are pharmaceutical drugs that act as antagonists at the calcium-sensing receptor (CaSR). This increases the secretion of parathyroid hormone (PTH), which has a temporary anabolic effect on bone tissue, producing an increase in both bone volume and bone density due to increased bone deposition and resorption. However, long term use of these causes resorption, degrading the bone to raise blood calcium. Consequently, these drugs have been researched for the treatment of osteoporosis, though with only limited success. More recent research has suggested a number of additional applications for these drugs, such as hyperresponsiveness and inflammation in allergic asthma.

Property Value
dbo:abstract
  • Calcilytics are pharmaceutical drugs that act as antagonists at the calcium-sensing receptor (CaSR). This increases the secretion of parathyroid hormone (PTH), which has a temporary anabolic effect on bone tissue, producing an increase in both bone volume and bone density due to increased bone deposition and resorption. However, long term use of these causes resorption, degrading the bone to raise blood calcium. Consequently, these drugs have been researched for the treatment of osteoporosis, though with only limited success. More recent research has suggested a number of additional applications for these drugs, such as hyperresponsiveness and inflammation in allergic asthma. (en)
dbo:wikiPageID
  • 46513471 (xsd:integer)
dbo:wikiPageLength
  • 5040 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1057474030 (xsd:integer)
dbo:wikiPageWikiLink
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Calcilytics are pharmaceutical drugs that act as antagonists at the calcium-sensing receptor (CaSR). This increases the secretion of parathyroid hormone (PTH), which has a temporary anabolic effect on bone tissue, producing an increase in both bone volume and bone density due to increased bone deposition and resorption. However, long term use of these causes resorption, degrading the bone to raise blood calcium. Consequently, these drugs have been researched for the treatment of osteoporosis, though with only limited success. More recent research has suggested a number of additional applications for these drugs, such as hyperresponsiveness and inflammation in allergic asthma. (en)
rdfs:label
  • Calcilytic (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License